PL3199161T3 - Preparat farmaceutyczny - Google Patents

Preparat farmaceutyczny

Info

Publication number
PL3199161T3
PL3199161T3 PL15844737T PL15844737T PL3199161T3 PL 3199161 T3 PL3199161 T3 PL 3199161T3 PL 15844737 T PL15844737 T PL 15844737T PL 15844737 T PL15844737 T PL 15844737T PL 3199161 T3 PL3199161 T3 PL 3199161T3
Authority
PL
Poland
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
PL15844737T
Other languages
English (en)
Inventor
Hiroshi Oda
Yuuki Suzuki
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3199161(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Publication of PL3199161T3 publication Critical patent/PL3199161T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/30Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3467Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
    • C08K5/3472Five-membered rings
    • C08K5/3475Five-membered rings condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • C08K2003/2237Oxides; Hydroxides of metals of titanium
    • C08K2003/2241Titanium dioxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Wrappers (AREA)
PL15844737T 2014-09-25 2015-09-25 Preparat farmaceutyczny PL3199161T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014195279 2014-09-25
PCT/JP2015/077015 WO2016047721A1 (ja) 2014-09-25 2015-09-25 医薬製剤
EP15844737.5A EP3199161B1 (en) 2014-09-25 2015-09-25 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
PL3199161T3 true PL3199161T3 (pl) 2022-04-11

Family

ID=55581240

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15844737T PL3199161T3 (pl) 2014-09-25 2015-09-25 Preparat farmaceutyczny

Country Status (17)

Country Link
US (2) US20170304199A1 (pl)
EP (1) EP3199161B1 (pl)
JP (6) JP6244038B2 (pl)
KR (1) KR101846804B1 (pl)
CN (1) CN106794186B (pl)
BR (1) BR112017006149A2 (pl)
CA (1) CA2962628C (pl)
DK (1) DK3199161T3 (pl)
ES (1) ES2901997T3 (pl)
HU (1) HUE057834T2 (pl)
MX (1) MX387483B (pl)
MY (1) MY178371A (pl)
PL (1) PL3199161T3 (pl)
PT (1) PT3199161T (pl)
SG (1) SG11201702298VA (pl)
TW (1) TWI671071B (pl)
WO (1) WO2016047721A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI686198B (zh) * 2014-09-25 2020-03-01 日商興和股份有限公司 醫藥品
JP2019142773A (ja) * 2016-06-15 2019-08-29 興和株式会社 眼科用組成物
JP6267839B1 (ja) * 2016-06-15 2018-01-24 興和株式会社 水性組成物
EP3590515A4 (en) * 2017-02-28 2020-12-23 Kowa Company, Ltd. DRUG PRODUCT
JP7045359B2 (ja) * 2017-02-28 2022-03-31 興和株式会社 医薬製剤
EP3590513A4 (en) * 2017-02-28 2020-12-30 Kowa Company, Ltd. DRUG
ES2972844T3 (es) * 2017-03-27 2024-06-17 Alcon Inc Preparación farmacéutica
WO2021195256A1 (en) * 2020-03-24 2021-09-30 Aerie Pharmaceuticals, Inc. Pharmaceutical preparation
JPWO2023195543A1 (pl) * 2022-04-08 2023-10-12
JP7783945B1 (ja) * 2024-07-22 2025-12-10 興和株式会社 医薬
WO2026022905A1 (ja) * 2024-07-22 2026-01-29 興和株式会社 医薬
JP7595233B1 (ja) * 2024-07-22 2024-12-05 興和株式会社 医薬
JP7663792B1 (ja) * 2024-07-22 2025-04-16 興和株式会社 医薬
WO2026022906A1 (ja) * 2024-07-22 2026-01-29 興和株式会社 医薬
JP7635471B1 (ja) * 2024-09-12 2025-02-25 興和株式会社 医薬製剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3879940B2 (ja) * 1995-07-11 2007-02-14 旭化成ファーマ株式会社 塩酸ファスジル注射剤
US6602447B2 (en) * 2001-08-21 2003-08-05 Milliken & Company Low-color ultraviolet absorbers for high UV wavelength protection applications
MY139797A (en) * 2004-11-29 2009-10-30 Kowa Co (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate
WO2006115244A1 (ja) * 2005-04-25 2006-11-02 D. Western Therapeutics Institute, Inc. 4-ブロモイソキノリン誘導体及びこれを含有する医薬
HRP20130876T1 (hr) * 2005-07-12 2013-10-25 Kowa Company, Ltd. Sredstvo za prevenciju ili lijeäśenje glaukoma
US20080064681A1 (en) * 2006-09-11 2008-03-13 Hiroyoshi Hidaka Therapeutic agent for treating glaucoma
JPWO2008096804A1 (ja) * 2007-02-07 2010-05-27 テイカ製薬株式会社 ラタノプロスト含有点眼剤
CN102099037A (zh) * 2008-07-25 2011-06-15 旭化成制药株式会社 含有磺酰胺化合物的稳定的水溶液组合物
WO2014174747A1 (ja) * 2013-04-24 2014-10-30 国立大学法人九州大学 眼底疾患治療剤
US10034885B2 (en) * 2014-09-24 2018-07-31 Kowa Company, Ltd. Corneal thickness modulating agent
TWI686198B (zh) * 2014-09-25 2020-03-01 日商興和股份有限公司 醫藥品
MY177032A (en) * 2014-09-25 2020-09-02 Kowa Co Aqueous composition
MX373700B (es) * 2014-12-12 2020-05-07 Kowa Co Composicion acuosa novedosa.
KR20160108121A (ko) * 2015-03-06 2016-09-19 코와 가부시키가이샤 수성 조성물
US9844556B2 (en) * 2015-03-25 2017-12-19 Megumi Honjo Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery
JP6928479B2 (ja) * 2017-05-12 2021-09-01 学校法人順天堂 拒絶反応抑制剤

Also Published As

Publication number Publication date
SG11201702298VA (en) 2017-04-27
PT3199161T (pt) 2022-02-08
CN106794186B (zh) 2020-06-05
CA2962628A1 (en) 2016-03-31
KR101846804B1 (ko) 2018-04-06
DK3199161T3 (da) 2022-01-03
MX387483B (es) 2025-03-18
EP3199161A1 (en) 2017-08-02
MY178371A (en) 2020-10-09
JP2021176842A (ja) 2021-11-11
JP2024174093A (ja) 2024-12-13
EP3199161A4 (en) 2018-04-11
JP6244038B2 (ja) 2017-12-06
TWI671071B (zh) 2019-09-11
EP3199161B1 (en) 2021-12-15
JP2018027979A (ja) 2018-02-22
US20170304199A1 (en) 2017-10-26
BR112017006149A2 (pt) 2017-12-26
US20240216272A1 (en) 2024-07-04
ES2901997T3 (es) 2022-03-24
CA2962628C (en) 2023-01-10
JPWO2016047721A1 (ja) 2017-06-22
HUE057834T2 (hu) 2022-06-28
WO2016047721A1 (ja) 2016-03-31
CN106794186A (zh) 2017-05-31
JP2020002151A (ja) 2020-01-09
MX2017003945A (es) 2017-06-30
TW201613603A (en) 2016-04-16
JP2023052792A (ja) 2023-04-12
KR20170058367A (ko) 2017-05-26

Similar Documents

Publication Publication Date Title
IL270954A (en) Pharmaceutical compounds
GB201404922D0 (en) Pharmaceutical compounds
SG11201702298VA (en) Pharmaceutical preparation
GB201409471D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
GB201416513D0 (en) Pharmaceutical compounds
GB201409485D0 (en) Pharmaceutical composition
GB201417707D0 (en) Pharmaceutical compounds
ZA201508726B (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
LT3089740T (lt) Farmacinė kompozicija
SG10201504332VA (en) Pharmaceutical Composition
GB201417589D0 (en) Pharmaceutical Formulations
GB201406115D0 (en) New pharmaceutical use
GB201409662D0 (en) New pharmaceutical use
PL3023093T3 (pl) Preparat leczniczy oparty na diosmektycie
GB201508022D0 (en) Pharmaceutical compounds
GB201411148D0 (en) New pharmaceutical uses
GB201416968D0 (en) Pharmaceutical compounds
GB201416969D0 (en) Pharmaceutical compounds
GB201416627D0 (en) Pharmaceutical compounds
GB201416625D0 (en) Pharmaceutical compounds
GB201416622D0 (en) Pharmaceutical compounds
GB201404896D0 (en) Pharmaceutical compounds
GB201402278D0 (en) Pharmaceutical compounds